← Eichor
Study identifier: NCT05768503 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC

Condition: Metastatic Microsatellite-stable Colorectal Cancer  ·  Sponsor: Sun Yat-sen University

PhasePhase 3
Planned participants176
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

This is a randomized, controlled, multicenter phase Ⅲ study to evaluate the therapeutic efficacy and safety of chidamide + sintilimab + bevacizumab versus standard second-line FOLFIRI + bevacizumab therapy in subjects with advanced microsatellite stable colorectal cancer who have failed first-line oxaliplatin-containing standard therapy. The primary purpose is to compare the progression-free survival (PFS) of chidamide + sintilimab + bevacizumab versus standard second-line FOLFIRI + bevacizumab therapy for colorectal cancer, with a planned enrollment of 176 subjects with advanced microsatellite stable colorectal cancer who have failed first-line oxaliplatin-containing standard therapy.

This description comes directly from the study's public registry record.

Talk to the study team

Ruihua Xu, MD  ·  +86 20 87343795  ·  xurh@sysucc.org.cn

Feng Wang, MD,PhD  ·  +86 20 87343795  ·  wangfeng@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (12)

Anhui Provincial Cancer HospitalHefei, Anhui, ChinaNot Yet Recruiting
The First People's Hospital of FoshanFoshan, Guangdong, ChinaNot Yet Recruiting
Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, ChinaRecruiting
The Third Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaNot Yet Recruiting
The First Affiliated Hospital of Guangxi Medical UniversityNanning, Guangxi, ChinaNot Yet Recruiting
Harbin Medical University Cancer HospitalHarbin, Heilongjiang, ChinaNot Yet Recruiting
Henan Cancer HospitalZhengzhou, Henan, ChinaNot Yet Recruiting
The First Affiliated Hospital of Nanchang UniversityNanchang, Jiangxi, ChinaNot Yet Recruiting
Ruijin Hospital, Shanghai Jiaotong University School of MedicineShanghai, Shanghai Municipality, ChinaNot Yet Recruiting
West China Hospital of Sichuan UniversityChengdu, Sichuan, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Kunming Medical UniversityKunming, Yunnan, ChinaNot Yet Recruiting
The First Affiliated Hospital of Zhejiang University College of MedicineHangzhou, Zhejiang, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05768503